Insider Selling Report: Kindred Biosciences Inc. [KIN]’s Dir, Bevers Denise, Sells 39,069 Shares
On Jan. 07, Bevers Denise divested U.S. $195,349 in shares of Kindred Biosciences Inc.. The Dir sold 39,069 shares at a price per share of $5.00. The transaction decreased this specific insider’s holdings to 143,835 shares worth around $0.72 million at present. Guggenheim took its Kindred Biosciences Inc. [KIN] rating to the equivalent of a […]
Kindred Biosciences, Inc. (KIN) Expanded Agreement with Vaxart To Gear Up Manufacturing Of COVID-19 and Other Vaccine Candidates
Kindred Biosciences, Inc. (KIN) this week came expanding an agreement with Vaxart, Inc. for the manufacturing of Vaxart’s oral vaccine for COVID-19 as well as other vaccine candidates. The biopharmaceutical company developing novel biologics will be performing manufacturing services through its wholly owned subsidiary Centaur Biopharmaceutical Services (Centaur), which is a provider of full service contract development […]
